Sign in: Staff/Students
Around one in five breast cancers are HER2-positive
Scientists from the University of Liverpool are investigating if a molecule called ‘WASH’ could be involved in the spread of a particularly aggressive form of breast cancer, known as HER2-positive.
With funding from the research charity, Breast Cancer Campaign, Dr Tobias Zech, from the University’s Institute of Translational Medicine, aims to understand whether blocking this molecule could be an effective breast cancer treatment.
Around one in five breast cancers – 10,000 cases per year in the UK – are HER2-positive, a particularly aggressive type of breast cancer where an increased amount of the HER2 protein gives cancer cells the ability to multiply and spread.
In order for the HER2 protein to be able to stimulate the growth and spread of breast tumours, it has to be continuously delivered to the surface of the breast cancer cell. The ‘WASH’ molecule is essential in returning HER2 to the surface of the cell.
Dr Zech said: “We believe that this study could show that preventing WASH from helping HER2 get back to the surface of the cell could lead to new treatments for this type of the disease and help stop the spread from the breast to other organs.”
Using breast tumour samples from the Breast Cancer Campaign Tissue Bank, Dr Zech will demonstrate whether the presence of ‘WASH’ could predict the chances of survival for people with HER2-positive breast cancer.
Katherine Woods, from Breast Cancer Campaign, said: “Despite targeted treatments, such as the drug Herceptin, some women with this type of the disease sadly still see their breast cancer spread to other parts of the body, where it cannot be cured.
“It is essential that we find new treatments that can tackle this type of the disease. Dr Zech’s research will bring us one step closer in this direction, and closer to our ambition that by 2020, 25% fewer people will develop secondary breast cancer.”
You must be logged in to post a comment.
All recent news
English Language Centre: Supporting international students on campus
University retains ‘2:1 Class’ sustainability ranking in People & Planet University League
Help us improve our social media to win £50 Everyman Cinema vouchers
Spiking: Staying safe
Everton CEO and Former MP receive honorary degrees from University of Liverpool
We were delighted to present ten esteemed figures with honorary degrees in a special ceremony @liverpoolphil yesterday including former MP @LouiseEllman, @Everton CEO Denise Barrett-Baxendale and @TheLegItPodcast host @AndyGbootneck.
Read more here 👉https://news.liverpool.ac.uk/2022/12/06/everton-ceo-and-former-mp-receive-honorary-degrees-from-university-of-liverpool/
An off-patent liver disease drug could prevent #COVID19 infection, a new @Nature study has found.
@livuniHLS scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients.
“This research is our voice. This research is all the voices everyone says they want to hear but no one wants to listen to”.
Research from @livuni, @ucl & @unisouthampton investigates the effects of Covid-19 on children seeking asylum in the UK. ⤵️